NEW YORK — U.S. stocks rallied to the brink of a record Thursday after more companies reported fatter profits than expected.

The S&P 500 advanced 1.0% on Thursday, Feb. 13, as an executive order deferred the possible implementation of reciprocal ...

Wuensch rates GE HealthCare stock at Buy with a $103 price target. Coming into Thursday, GE HealthCare stock has risen about ...

GE HealthCare expects revenues to grow 2% to 3% year-over-year. The company said its projection reflects continued demand for ...

Citi raised the firm’s price target on GE HealthCare (GEHC) to $110 from $103 and keeps a Buy rating on the shares. Operating margins expanded ...

U.S. stocks are rising as big companies keep reporting bigger profits than expected. Wall Street also mostly yawned Thursday ...

Howard Temin was a UW-Madison scientist who shared the 1975 Nobel Prize for his discovery of “reverse transcriptase,” which described how tumor viruses ...

GE HealthCare Q4 earnings beat estimates with strong U.S. demand. 2025 outlook includes 2%-3% revenue growth and EPS guidance of $4.61-$4.75.

Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...